李嘉華(0 0) 教授

Email
chlee@tmu.edu.tw
現   職
醫學檢驗暨生物技術學系 教授

學經歷

學 歷

畢業學校與學位[修業時間]
臺北醫學大學醫學科學研究所 博士
2005/09/01~2011/01/31
臺北醫學大學生技所 碩士
2003/09/01~2005/06/30
臺北醫學大學醫技系 學士
2002/09/01~2003/06/30

本校學術經歷

任職單位與職稱[起迄時間]
醫學檢驗暨生物技術學系教授
2022/08/01~
醫學檢驗暨生物技術學系副教授
2018/02/01~2022/07/31
醫學檢驗暨生物技術學系助理教授
2012/02/29~2018/01/31

本校兼職教學行政經歷

服務單位與職稱[起迄時間]
醫學生物科技博士學位學程籌備處助理教授
2015/02/01 ~

其它經歷

任職單位與職稱[起迄時間]
臺北醫學大學博士後研究員
2011/01/01~2012/02/28

專長與研究領域

學門領域
醫學生化及分子生物
Medical Biochemistry and Molecular Biology
寄生蟲及醫技與實驗診斷
Parasitology, Medical Technology, and Clinical Pathology
學術專長
抗癌藥物
抗癌藥物
癌症分子醫學
癌症分子醫學
癌症基因治療
癌症基因治療
寄生蟲學醫事技術及實驗診斷
Parasitology, Medical Technology, and Clinical Pathology

論文著作

清冊下載


1. 2024 Gene set correlation enrichment analysis for interpreting and annotating gene expression profiles . Nucleic Acids Research .2024 ;(52)

2. 2024 Chia-Hwa Lee,Kai-Wen Hsu,Yao-Yu Hsieh,Wei-Ting Li,Yuqing Long,Chun-Yu Lin and Shu-Huey Chen. Unveiling IL6R and MYC as Targeting Biomarkers in Imatinib-Resistant Chronic Myeloid Leukemia Through Advanced NI-ADS v2 Detection . Cells .2024 ;(13):616

3. 2024 Peiyu Wang,Renwu Zhou, Rusen Zhou, Shuo Feng, Liqian Zhao,Wenshao Li, Jinyong Lin, Aleksandra Rajapakse, Chia-Hwa Lee, Frank B Furnari, Antony W Burgess, Jennifer H Gunter, Gang Liu, Kostya Ken Ostrikov, Derek J Richard, Fiona Simpson, Xiaofeng Dai, Erik W Thompson. Epidermal Growth Factor potentiates EGFR(Y992/1173)-mediated therapeutic response of triple negative breast cancer cells to cold atmospheric plasma-activated medium . Redox Biology .2024 ;(69):102976

4. 2023 Syahru Agung Setiawan,Winston Zhenhao Liu,Pei-Wei Weng,Chia Hwa Lee,Vijesh Kumar Yadav,Mardiah Suci Hardianti, Chi-Tai Yeh, Tsu-Yi Chao. Synergistic disruption of BTK and BCL-2 causes apoptosis while inducing ferroptosis in double-hit lymphoma . European Journal of Pharmacology .2023 ;(943):175526

5. 2023 Hsin-Hua Chen,Chun-Wei Hsueh,Chia-Hwa Lee,Ting-Yi Hao,Tzu-Ying Tu,Lan-Yun Chang, Jih-Chin Lee, Chun-Yu Lin. SWEET: a single-sample network inference method for deciphering individual features in disease . Briefings in Bioinformatics .2023 ;(24):1-15

6. 2022 Ming-Lin Tsai,Chia-Hwa Lee,Li-Chi Huang,Yu-Hsin Chen,Wei-Ni Liu,Chun-Yu Lin,Kai-Wen Hsu,Ai-Wei Lee,Ching-Ling Lin. CRISPR-mediated knockout of VEGFR2/KDR inhibits cell growth in a squamous thyroid cancer cell line . FEBS Open Bio .2022 ;(12)

7. 2022 Hou-Hsien Liu,Chia-Hwa Lee,Yi-Chen Hsieh,Jia-Huei Zheng,Yun-Ru Liu,Chia-Hsuan Chang, Er-Chieh Cho. Mitochondrial Factor C20orf7 Facilitates the EMT-Mediated Cancer Cell Migration and the Proliferation of Colon Cancer In Vitro and In Vivo . Genes .2022 ;(13):2111-2123

8. 2021 Ching-Ling Lin,Ming-Lin Tsai,Yu-hsin Chen,Wei-Ni Liu,Chun-Yu Lin,Kai-Wen Hsu, Chien-Yu Huang, Yu-Jia Chang, Po-Li Wei, Shu-Huey Chen, Li-Chi Huang and Chia-Hwa Lee. Platelet-derived growth factor receptor-α subunit targeting suppresses metastasis in advanced thyroid cancer in vitro and in vivo . Biomolecules & Therapeutics .2021

9. 2021 Hou-Hsien Liu,Chia-Hwa Lee,Yi-Chen Hsieh,Duen-Wei Hsu,Er-Chieh Cho. Multiple myeloma driving factor WHSC1 is a transcription target of oncogene HMGA2 that facilitates colon cancer proliferation and metastasis . Biochemical and Biophysical Research Communications .2021

10. 2020 Shu-Huey Chen,Yao-Yu Hsieh,Huey-En Tzeng,Chun-Yu Lin,Kai-Wen Hsu,Yun-Shan Chiang, Su-Mei Lin, Ming-Jang Su, Wen-Shyang Hsieh, Chia-Hwa Lee. ABL genomic editing sufficiently abolishes oncogenesis of human chronic myeloid leukemia cells in vitro and in vivo . Cancers .2020 ;(12):1399-1423

11. 2020 Yi-Hsuan Chuang,Chia-Hwa Lee,Chun-Yu Lin,Chia-Lin Liu,Sing-Han Huang,Jung-Yu Lee, Yi-Yuan Chiu, Jih‐Chin Lee, Jinn-Moon Yang. An integrated genomic strategy to identify CHRNB4 as a diagnostic/prognostic biomarker for targeted therapy in head and neck cancer . Cancers .2020 ;(12):1324-1347

12. 2019 Jie‐Ying Wu,Ya‐Ting Chang,Ying‐Chin Lin,Chia‐Hwa Lee,El‐Wui Loh,Mei‐Yi Wu, Yu‐Sheng Chang, Ka‐Wai Tam. Efficacy and Safety of Lesinurad in Patients with Hyperuricemia Associated with Gout: A Systematic Review and Meta-Analysis of Randomized Controlled Trials . Pharmacotherapy .2019 ;(38):1106-1119

13. 2019 Ching-Ling Lin,Ming-Lin Tsai,Chun-Yu Lin,Kai-Wen Hsu,Wen-Shyang Hsieh,Wei-Ming Chi, Li-Chi Huang, Chia-Hwa Lee. HDAC1 and HDAC2 Double Knockout Triggers Cell Apoptosis in Advanced Thyroid Cancer. . International Journal of Molecular Sciences .2019 ;(20):454-467

14. 2019 Shu-Huey Chen,Jyh-Ming Chow,Yao-Yu Hsieh,Chun-Yu Lin,Kai-Wen Hsu,Wen-Shyang Hsieh, Wei-Ming Chi, Beished M. Shabangu, Chia-Hwa Lee. HDAC1,2 Knock-Out and HDACi Induced Cell Apoptosis in Imatinib-Resistant K562 Cells . International Journal of Molecular Sciences .2019 ;(20):2271-2287

15. 2019 Lin Chun-Yu,Lee Chia-Hwa,Chuang Yi-Hsuan,Lee Jung-Yu,Chiu Yi-Yuan,Wu Lee Yan-Hwa, Ho Yuan-Soon, Yang Jinn-Moon. Membrane protein-regulated networks across human cancers . Nature Communications .2019 ;(10):3131-3148

16. 2018 Precious Takondwa Makondi, Chia-Hwa Lee,Chien-Yu Huang,Chi-Ming Chu,Yu-Jia Chang,Po-Li Wei. Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer . PLoS One .2018 ;(13)

17. 2018 Chien-Yu Huang,Chia-Hwa Lee,Chao-Chiang Tu,Chih-Hsiung Wu,Ming-Te Huang,Po-Li Wei, Yu-Jia Chang. Glucose-regulated protein 94 mediates progression and metastasis of esophageal squamous cell carcinoma via mitochondrial function and the NFkb/COX-2/VEGF axis . Oncotarget .2018 ;(9):9425-9441

18. 2018 Huang YH,Chen C,Lee CH,Loh EW,Tam KW. Wound Closure after thyroid and Parathyroid surgery: a Meta-analysis of randoMized Controlled trials . Scandinavian Journal of Surgery .2018 ;(1457496918798203):1-8

19. 2018 Li-Chi Huang,Ka-Wai Tam,Wei-Ni Liu,Chun-Yu Lin,Kai-Wen Hsu,Wen-Shyang Hsieh, Wei-Ming Chi, Ai-Wei Lee, Jinn-Moon Yang, Ching-Ling Lin, Chia-Hwa Lee. CRISPR/Cas9 genome editing of Epidermal Growth Factor Receptor sufficiently abolished oncogenicity in Anaplastic Thyroid cancer. . Disease Markers .2018 ;(2018)

20. 2018 Kai-Wen Hsu,Chien-Yu Huang,Ka-Wai Tam,Chun-Yu Lin,Li-Chi Huang,Ching-Ling Lin, Wen-Shyang Hsieh, Wei-Ming Chi, Yu-Jia Chang, Po-Li Wei, Shou-Tung Chen, Chia-Hwa Lee. The Application of Non-Invasive Apoptosis Detection Sensor (NIADS) on Histone Deacetylation Inhibitor (HDACi)-Induced Breast Cancer Cell Death . International Journal of Molecular Sciences .2018 ;(19)

21. 2018 Lawrence Chen,Yi-Hsiu Wu,Chia-Hwa Lee,Hsin-An Chen,El-Wui Loh,Ka-Wai Tam. Prophylactic Central Neck Dissection for Papillary Thyroid Carcinoma with Clinically Uninvolved Central Neck Lymph Nodes: A Systematic Review and Meta-analysis . World Journal of Surgery .2018 ;(42):2846-2857

22. 2017 Chin-Sheng Hung,Chien-Yu Huang,Chia-Hwa Lee,Wei-Yu Chen,Ming- Te Huang,Po-Li Wei, Yu-Jia Chang. IGFBP2 plays an important role in heat shock protein 27-mediated cancer progression and metastasis. . Oncotarget .2017 ;(8):54978-54992

23. 2017 Yi-Chen Hsieh,Er-Chieh Cho,Shih-Hsin Tu,Chih-Hsiung Wu,Chin-Sheng Hung,Mao-Chih Hsieh, Chien-Tien Su, Yun-Ru Liu, Chia-Hwa Lee, Yuan-Soon Ho, Hung-Yi Chiou. MSH2 rs2303425 Polymorphism is Associated with Early-Onset Breast Cancer in Taiwan . Annals of Surgical Oncology. .2017 ;(24):603-610

24. 2017 Shih-Hsin Tu,Yi-Chen Hsieh,Li-Chi Huang,Chun-Yu Lin,Kai-Wen Hsu,Wen-Shyang Hsieh, Wei-Ming Chi, Chia-Hwa Lee. A Rapid and Quantitative Method to Detect Human Circulating Tumor Cells in a Preclinical Animal Model. . BMC CANCER .2017 ;(17):440-450

25. 2017 Jen-Wei Liu,Chieh-feng Chen,El-Wui Loh,Chun-Cheng Chu,Mu-Yi Wang,Hsin-Ju Ouyang, Ya-Ting Chang, Wei-Zhan Zhuang, Ching-Wen Chou, Der-Jr Huang, Chia-Hwa Lee, Yun Yen, Ka-Wai Tam. Tyrosine kinase inhibitors for advanced or metastatic thyroid cancer: a meta-analysis of randomized controlled trials. . Curr Med Res Opin .2017

26. 2017 Li-Chi Huang,Ching-Ling Lin,Jia-Zheng Qiu,Chun-Yu Lin,Kai-Wen Hsu,Ka-Wai Tam, Jung-Yu Lee, Jinn-Moon Yang, Chia-Hwa Lee. Nicotinic Acetylcholine Receptor Subtype Alpha-9 Mediates Triple-Negative Breast Cancers Based on a Spontaneous Pulmonary Metastasis Mouse Model. . Frontiers in Cellular Neuroscience. .2017 ;(11)

27. 2017 Ka-Wai Tam,Chi-Tang Ho,Shih-Hsin Tu,Wen-Jui Lee,Ching-Shui Huang,Ching-Shyang Chen, Chih-Hsiung Wu, Chia-Hwa Lee, Yuan-Soon Ho. α-Tocopherol Succinate Enhances Pterostilbene Anti-Tumor Activity in Human Breast Cancer Cells In Vivo and In Vitro. . Oncotarget .2017 ;(9):4593-4606

28. 2014 Yi-Chen Hsieh,Chia-Hwa Lee,Shih-Hsin Tu,Chih-Hsiung Wu,Chin-Sheng Hung,Mao-Chih Hsieh, Ching-Wen Chuang. CHRNA9 polymorphisms and smoking exposure synergize to increase the risk of breast cancer in Taiwan. . Carcinogenesis .2014 ;(35):2520-2525

29. 2013 Ka-Wai Tam,Chi-Tang Ho,Wen-Jui Lee,Shih-Hsin Tu,Ching-Shui Huang,Ching-Shyang Chen, Chia-Hwa Lee, Chih-Hsiung Wu, Yuan-Soon Ho. Alteration of α-tocopherol-associated protein (TAP) expression in human breast epithelial cells during breast cancer development. . Food Chemistry .2013 ;(138):1015-1021

30. 2013 Li-Ching Chen,Shih-Hsin Tu,Ching-Shui Huang,Ching-Shyang Chen,Chi-Tang Ho,Chia-Hwa Lee, Hui-Wen Chang, Chien-Hsi Chang, Chih-Hsiung Wu, Wen-Sen Lee, Yuan-Soon Ho. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin signaling pathway. . Breast Cancer Research and Treatment .2013

31. 2012 Tu SH,Ku CY,Ho CT,Chen CS,Huang CS,Lee CH, Chen LC, Pan MH, Chang HW, Chang CH, Chang YJ, Wei PL, Wu CH, Ho YS. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits nicotine- and estrogen-induced alpha9-nicotinic acetylcholine receptor upregulation in human breast cancer cells. . Molecular Nutrition and Food Research .2012 ;(55):455-466

32. 2012 Le CH,Chang YC,Chen CS,Tu SH,Wang YJ,Chen LC, Chang YJ, Wei PL, Chang HW, Chang CH, Huang CS, Wu CH, Ho YS. Crosstalk between nicotine and estrogen-induced estrogen receptor activation induces alpha9-nicotinic acetylcholine receptor expression in human breast cancer cell. . Breast Cancer Research and Treatment .2012 ;(129):331-345

33. 2012 Ho YS,Lee CH,Wu CH. Smoking-induced human breast cancer formation through induction of alpha9-nicotinic acetylcholine receptor. . Formosan Journal of Surgery .2012 ;(44):47-52

34. 2011 Lee CH,Wu CH,Ho YS. From Smoking to Cancers: Novel Targets to Neuronal Nicotinic Acetylcholine Receptors. . Journal of Oncology. .2011 ;(2011):693424

35. 2011 Wu CH,Lee CH,Ho YS. Nicotinic acetylcholine receptor-based blockade: Applications of molecular target for cancer therapy. . Clinical Cancer Research .2011 ;(17):3533-3541

36. 2011 Chen CS,Lee CH,Hsieh CD,Ho CT,Pan MH,Huang CS, Tu SH, Wang YJ, Chen LC, Chang YJ, Wei PL, Yang YY, Wu CH, Ho YS. Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins. . Breast Cancer Research and Treatment .2011 ;(125):73-87

37. 2010 Lee CH,Huang CS,Chen CS,Tu SH,Wang YJ,Chang YJ, Tam KW, Wei PL, Cheng TC, Chu JS, Chen LC, Wu CH, Ho YS. Overexpression and activation of the alpha9-nicotinic receptor during tumorigenesis in human breast epithelial cells. . Journal of the National Cancer Institute .2010 ;(102):1322-1335

38. 2010 Tu SH,Chang CC,Chen CS,Tam KW,Wang YJ,Lee CH, Lin HW, Huang TC, Chu CS, Shih NY, Chen LC, Leu SJ, Ho YS, Wu CH. Increased expression of enolase alpha in human breast cancer confers tamoxifen resistance in human breast cancer cells. . Breast Cancer Research and Treatment .2010 ;(121):539-553

39. 2010 Huang CS,Lee YR,Chen CS,Tu SH,Wang YJ,Lee CH, Chen LC, Chang HW, Chang CH, Su CM, Wu CH, Ho YS. Long-term ethanol exposure causes human liver cancer cells to become resistant to mitomycin C treatment through the inactivation of bad-mediated apoptosis. . Molecular Carcinogenesis .2010 ;(49):728-738

40. 2009 Wei PL,Chang YJ,Ho YS,Lee CH,Yang YY,An J, Lin SY. Tobacco-specific carcinogen enhances colon cancer cell migration through alpha7-nicotinic acetylcholine receptor. . Annals of Surgery .2009 ;(249):978-985

41. 2009 Wu CH,Ho YS,Tsai CY,Wang YJ,Tseng H,Wei PL, Lee CH, Liu RS, Lin SY. In vitro and in vivo study of phloretin-induced apoptosis in human liver cancer cells involving inhibition of type II glucose transporter. . International Journal of Cancer .2009 ;(124):2210-2219

42. 2009 Yang KC,Tsai CY,Wang YJ,Wei PL,Lee CH,Chen JH, Wu CH, Ho YS. Apple polyphenol phloretin potentiates the anticancer actions of paclitaxel through induction of apoptosis in human hep G2 cells. . Molecular Carcinogenesis .2009 ;(48):420-431

43. 2009 Wang X,Ni J,Hsu CL,Johnykutty S,Tang P,Ho YS, Lee CH, Yeh S. Reduced expression of tocopherol-associated protein (TAP/Sec14L2) in human breast cancer. . Cancer Investigation .2009 ;(27):971-977

44. 2008 Huang CS,Ho WL,Lee WS,Sheu MT,Wang YJ,Tu SH, Chen RJ, Chu JS, Chen LC, Lee CH, Tseng H, Ho YS, Wu CH. SP1-regulated p27/Kip1 gene expression is involved in terbinafine-induced human A431 cancer cell differentiation: an in vitro and in vivo study. . Biochemical Pharmacology .2008 ;(75):1783-1796

45. 2007 Chou YH,Ho YS,Wu CC,Chai CY,Chen SC,Lee CH, Tsai PS, Wu CH. Tubulozole-induced G2/M cell cycle arrest in human colon cancer cells through formation of microtubule polymerization mediated by ERK1/2 and Chk1 kinase activation. . Food Chemistry and Toxicology .2007 ;(45):1356-1367

46. 2006 Yang KC,Wu CC,Wu CH,Chen JH,Chu CH,Chen CH, Chou YH, Wang YJ, Lee WS, Tseng H, Lin SY, Lee CH, Ho YS. Involvement of proapoptotic Bcl-2 family members in terbinafine-induced mitochondrial dysfunction and apoptosis in HL60 cells. . Food Chemistry and Toxicology .2006 ;(44):214-226

47. 2005 Ho YS,Wu CH,Chou HM,Wang YJ,Tseng H,Chen CH, Chen LC, Lee CH, Lin SY. Molecular mechanisms of econazole-induced toxicity on human colon cancer cells: G0/G1 cell cycle arrest and caspase 8-independent apoptotic signaling pathways. . Food Chemistry and Toxicology .2005 ;(43):1483-1495

48. 2005 Ho YS,Chen CH,Wang YJ,Pestell RG,Albanese C,Chen RJ, Chang MC, Jeng JH, Lin SY, Chen LC, Lee CH, Tso WL, Lai YC, Wu CH. Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFkappaB activation and cyclin D1 up-regulation. . Toxicology and Applied Pharmacology .2005 ;(205):133-148

研究計畫

計畫名稱
112 透過活體動物高轉移乳癌模式及全基因 剔除研究平台(Genome-scale CRISPR- Cas9 Knockout,GeCKO)評估GSDMC基因 作為乳癌轉移標靶治療有效性探討
補助單位
國家科學及技術委員會

計畫名稱
112 利用全基因組剔除研究平台(Genome- Scale CRISPR Knock-Out,GeCKO)篩選 CDC20基因並以CRISPR/Cas9基因剪輯探 討其在雙打擊瀰漫性大B細胞瘤(DHL)上 抗癌機制
補助單位
國家科學及技術委員會

計畫名稱
112 113年度臺英(NSTC-RS)雙邊合作人員交流計畫-以單細胞分析與基因剪輯探討炎症微環境動態變化與疾病惡性化機制與治療策略(1/2)
補助單位
國家科學及技術委員會

計畫名稱
112 以跨世代活體高轉移乳癌模型與全基因組剔除(GeCKO)分析模式探討尿苷雙磷酸葡萄糖醛酸基轉移酶2B7(UGT2B7)標靶抗癌機制
補助單位
國家科學及技術委員會

計畫名稱
111 建立SARS-CoV-2 nsp5內切酶活性冷光檢測平台篩選抗病毒藥物-以Omicron變異株為例
補助單位
國家科學及技術委員會

計畫名稱
111 以活體肺轉移研究平台與全基因剔除模式(GeCKO)探討未分化甲狀腺癌轉移與基因調控-以TNFRSF19、CTDP1基因開發抗甲狀腺癌策略為例
補助單位
國家科學及技術委員會

計畫名稱
111 以尿苷雙磷酸葡萄糖醛酸基轉移酶2B7 (UGT2B7) 開發新穎三陰性乳癌標靶治療策略(3/3)
補助單位
國家科學及技術委員會

計畫名稱
110 以尿?雙磷酸葡萄糖醛酸基轉移?2B7 (UGT2B7) 開發新穎三陰性乳癌標靶治療策略(2/3)
補助單位
科技部

計畫名稱
109 以CRISPR/Cas9建立exosome-free研究模式探討外泌體(exosome)調控三陰性乳癌轉移機制
補助單位
科技部

計畫名稱
109 以CRISPR/cas9開發三陰性乳癌轉移中iPS相關基因作為標靶研究平台
補助單位
科技部

計畫名稱
109 以尿苷雙磷酸葡萄糖醛酸基轉移酶2B7 (UGT2B7) 開發新穎三陰性乳癌標靶治療策略(1/3)
補助單位
科技部

計畫名稱
109 醫學檢驗暨生物技術學系李嘉華副教授申請補助延攬科技人才廖皎君君參與「以尿苷雙磷酸葡萄糖醛酸基轉移酶2B7 (UGT2B7) 開發新穎三陰性乳癌標靶治療策略(1/3)」研究計畫案
補助單位
科技部

計畫名稱
108 以新穎mito-FD-CRISPR/Cas9系統開發粒線體基因編輯模式
補助單位
科技部

計畫名稱
108 以單點基因編輯(single base editing)作為KRAS基因突變校正之抗癌治療研究
補助單位
科技部

計畫名稱
107 以NIADS優化TNBC藥物篩檢平台並以基因編輯技術探討IL6R及IL7R在乳癌轉移所扮演的角色
補助單位
科技部

計畫名稱
105 以基因剪輯技術(CRISPR/Cas9)應用於費城染色體為標靶之慢性骨髓性白血病治療
補助單位
科技部

計畫名稱
105 醫學檢驗暨生物技術學系李嘉華助理教授擬於106年6月赴澳大利亞雪梨參加International Conference on Oncology & Cancer Science
補助單位

計畫名稱
104 以尼古丁乙醯膽鹼受體拮抗劑發展乳癌細胞賀癌平(Herceptin)抗藥性之對策研究與新穎藥物開發(3/3)
補助單位
科技部

計畫名稱
104 以尼古丁乙醯膽鹼受體拮抗劑發展乳癌細胞賀癌平(Herceptin)抗藥性之對策研究與新穎藥物開發(3/3)
補助單位
科技部

計畫名稱
103 以尼古丁乙醯膽鹼受體拮抗劑發展乳癌細胞賀癌平(Herceptin)抗藥性之對策研究與新穎藥物開發(2/3)
補助單位
行政院國家科學委員會

計畫名稱
102 以尼古丁乙醯膽鹼受體拮抗劑發展乳癌細胞賀癌平(Herceptin)抗藥性之對策研究與新穎藥物開發(1/3)
補助單位
行政院國家科學委員會

計畫名稱
102 以尼古丁乙醯膽鹼受體拮抗劑發展乳癌細胞賀癌平(HERCEPTIN)抗藥性之對策研究與新穎藥物開發(1-3)
補助單位
科技部

計畫名稱
102 以尼古丁乙醯膽鹼受體拮抗劑發展乳癌細胞賀癌平(HERCEPTIN)抗藥性之對策研究與新穎藥物開發(2/3)
補助單位
科技部